TrialRheumatology (Oxford, England)2023

Risankizumab improved health-related quality of life, fatigue, pain and work productivity in psoriatic arthritis: results of KEEPsAKE 1.

Lars Erik Kristensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.